Table 1.
Treatment | LH (ng/ml) |
---|---|
P30, sham/OVX at P15 | |
Sham | 0.32 ± 0.10 |
OVX | 1.83 ± 0.40a |
P60, sham/OVX at P15 | |
Sham | 0.20 ± 0.01 |
OVX | 4.07 ± 0.53b |
P30, sham/OVX at P15 ± E2 P15–30 | |
Sham | 0.29 ± 0.05 |
OVX + vehicle | 1.50 ± 0.23a |
OVX + E2 | 0.39 ± 0.13 |
P30, sham/OVX at P15 ± E2 P22–30 | |
Sham | 0.24 ± 0.02 |
OVX + vehicle | 1.98 ± 0.26a |
OVX + E2 | 0.77 ± 0.21 |
P < 0.05 compared with sham, and OVX plus E2 where included.
P < 0.01 compared with sham, and OVX plus E2 where included.